Before revision: B-cell chronic lymphocytic leukemia/small cell lymphoma 3 to 4% of lymphomas in adults Small resting lymphocytes mixed with variable numbers of large activated cells, lymph nodes diffusely effaced CD5, surface immunoglobulin 5-year survival rate 50%.
After revision: B-cell chronic lymphocytic leukemia/small cell lymphoma 3 – 4% of lymphomas in adults Small resting lymphocytes mixed with variable numbers of large activated cells, lymph nodes diffusely effaced CD5, surface immunoglobulin 5-year survival rate 50%.